Holen Sie sich die Stockscreener-App
7.85
0.63%
-0.05
Handel nachbörslich:
7.80
-0.05
-0.64%
Finanzdaten der Karyopharm Therapeutics Inc-Aktie (KPTI)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
22.63%
34.08
|
44.04 | 37.93 | 30.02 | 38.78 |
Operating Expenses
|
12.39%
51.92
|
59.26 | 62.32 | 63.27 | 65.07 |
| Benefits Costs and Expenses |
76.76%
136.34
|
77.14 | 75.14 | 53.44 | 70.83 |
| Costs And Expenses |
76.76%
136.34
|
77.14 | 75.14 | 53.44 | 70.83 |
| Operating Income/Loss |
17.24%
-17.84
|
-15.22 | -24.39 | -33.26 | -26.28 |
| Nonoperating Income/Loss |
372.34%
-84.42
|
-17.87 | -12.82 | 9.83 | -5.761 |
| Income/Loss From Continuing Operations Before Tax |
209.02%
-102.27
|
-33.09 | -37.21 | -23.43 | -32.04 |
| Income Tax Expense/Benefit |
297.06%
-0.067
|
0.034 | 0.04 | 0.036 | 0.028 |
| Income/Loss From Continuing Operations After Tax |
208.50%
-102.20
|
-33.13 | -37.25 | -23.46 | -32.07 |
|
Net Income/Loss
|
208.50%
-102.20
|
-33.13 | -37.25 | -23.46 | -32.07 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
72.91%
0.00235
|
0.00867 | 0.00862 | 0.00847 | 0.125 |
| Diluted Average Shares |
72.91%
0.00235
|
0.00867 | 0.00862 | 0.00847 | 0.125 |
| Basic Earnings Per Share |
83.25%
-7.00
|
-3.82 | -4.32 | -2.77 | -0.26 |
| Diluted Earnings Per Share |
83.25%
-7.00
|
-3.82 | -4.32 | -2.77 | -0.26 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):